磺脲类降糖药物与心血管风险
Relationship between sulfonylurea drugs and cardiovascular risk
摘要
随着生活方式的改变，2型糖尿病发病率呈增长趋势。流行病学调查显示2008年我国20岁以上糖尿病发病率已达到9．7％，中国已成为糖尿病大国^[1]。而磺脲类降糖药物（SUs）是发现最早和使用最广泛的口服降糖药，关于磺脲类药物的心血管安全性自上世纪七十年代以来一直是关注的热点，不同的研究其结果也不尽相同，充分理解磺脲类药物的心血管影响对指导临床用药意义重大。
出处
《药品评价》
CAS
2011年第23期18-19,24,共3页
Drug Evaluation
参考文献18
-
1Yang W,Lu J,Weng J,et al.Prevalence of diabetes among men and women in China[J].N Engl J Med,2010,362(12):1090-1101.
-
2Meinert CL,Knatterud G,Lrout TE,et al.A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes[J].Diabetes,1970,19:789-830.
-
3Brady PA,Terric A.The sulfonyhurea controversy:more questions from the heart[J].J AM Coil Cardiol,1998,31(5):950-56.
-
4Gross G,Auchampach JA.Blockade of ATP-sensitive potassium channels prevents myocardial preconditioning in dogs[J].Circ Res,1992,70:223-233.
-
5Yokoshiki H,Sunagawa M,Seki T,et al.ATP-sensitive K+ channels in pancreatic,cardiac,and vascular smooth muscle cells[J].Am J Physiol,1998,274(1 pt 1):C25-37.
-
6Tomai F,Crea F,Gaspardone A,et al.Ischemic preconditioning during coronary angioplasty is prevented by glibenclamide,a selective ATP-sensitive K+ channel blocker[J].Circulation,1994,90:700-705.
-
7Toombs CF,Moore TL,Shebuski RJ.Limitation of infart size in the rabbit by ischemic preconditioning is reversible with glibenclamide[J].Cardivasc Res,1993,27:617-622.
-
8Garratt KN,Brady PA,Hassinger NL,et al.Sulfonylurea drugs increase early mortality in patients with diabetes mellitus after direct angioplasty for acute myocardial infarction[J].J AM Coll Cardiol,1999,33:119-124.
-
9Halkin A,Roth A,Jenas M,et al.Sulfonylureas are not associasted with increased mortality in diabetic treated with thrombolysis for acute myocardial infarction[J].J Thromb Thrombolysis,2001,12(2):177-184.
-
10UK Prosepetive Diabetes Study(UKPDS) Group Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes(UKPDS 33)[J].Lancet,1998,352:837-853.
-
1杨肖红,黄秀珍,王枫.胰岛素加磺脲类药物联合治疗Ⅱ型糖尿病[J].辽宁实用糖尿病杂志,2001,9(3):36-36. 被引量：2
-
2郑景晨.磺脲类降糖药物对体重的影响[J].药品评价,2011,8(23):14-17. 被引量：3
-
3詹志伟.磺脲类降糖药服用注意事项[J].糖尿病之友,2006(5):45-45.
-
4孙秀芹.格列美脲治疗2型糖尿病54例疗效观察[J].中国基层医药,2008,15(7):1215-1215. 被引量：2
-
5杨凯杰.药片能否掰成1／4片吃？[J].糖尿病之友,2011(3):71-71.
-
6闫振成.新机制、新希望——口服降糖药西格列汀[J].糖尿病之友,2011(7):55-55.
-
7封飚,刘辉,贺兴义,宣慧仁.盐酸戊乙奎醚用于老年病人术前用药的临床观察[J].临床麻醉学杂志,2006,22(4):311-311. 被引量：6
-
8李华,姚琰,郝勇.治疗糖尿病药物的若干进展(一)[J].医药导报,1999,18(4):235-236. 被引量：6
-
9药物警戒快讯[J].中国药物警戒,2016,13(1):61-64.
-
10王建华.应用口服降糖药的细节及要点[J].心血管病防治知识,2016,0(5):15-19. 被引量：1
